KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInvested CapitalMarket Capitalization

AbCellera Biologics (ABCL) FCF Margin: 2020-2023

Historic FCF Margin for AbCellera Biologics (ABCL) over the last 4 years, with Dec 2023 value amounting to -370.87%.

  • AbCellera Biologics' FCF Margin fell 45712.00% to -370.87% in Q4 2023 from the same period last year, while for Dec 2023 it was -317.74%, marking a year-over-year decrease of 36032.00%. This contributed to the annual value of -648.40% for FY2024, which is 33065.00% down from last year.
  • Per AbCellera Biologics' latest filing, its FCF Margin stood at -370.87% for Q4 2023, which was down 19.75% from -309.70% recorded in Q3 2023.
  • AbCellera Biologics' 5-year FCF Margin high stood at 526.37% for Q2 2022, and its period low was -484.31% during Q1 2023.
  • In the last 3 years, AbCellera Biologics' FCF Margin had a median value of -45.67% in 2021 and averaged -43.98%.
  • Per our database at Business Quant, AbCellera Biologics' FCF Margin soared by 23,891bps in 2021 and then tumbled by 59,894bps in 2023.
  • Quarterly analysis of 4 years shows AbCellera Biologics' FCF Margin stood at -0.11% in 2020, then crashed by 1,865bps to -18.76% in 2021, then skyrocketed by 10,501bps to 86.25% in 2022, then crashed by 45,712bps to -370.87% in 2023.
  • Its FCF Margin stands at -370.87% for Q4 2023, versus -309.70% for Q3 2023 and -72.57% for Q2 2023.